Generic Entecavir Hepatitis B Treatment Approved
A generic equivalent to Bristol-Myers Squibb’s entecavir (Baraclude) hepatitis B treatment has been approved by the FDA. Aurobindo Pharma’s generic entecavir will soon be available in 0.5 mg and 1 mg oral tablet strengths. Entecavir is a nucleoside analogue indicated … Continue reading →